Trine Lindhardt Plesner

Author

Also Known As

Plesner, Trine Lindhardt, T Plesner, T. Plesner, Trine L Plesner, Trine L. Plesner, Trine Lindhardt Plesner, Trine Plesner

Publications

896

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Copenhagen University Hospital Aarhus University Rigshospitalet Vejle Sygehus

About

Trine Lindhardt Plesner is an author at Aarhus University Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	449
2	Immunology	3	3	137
3	Engineering	1	1	312
4	Cell Biology	1	1	11
5	Orthopaedics	1	1	312

Trine Lindhardt Plesner

Publications

823

Citations

H-Index

Page 1

	Year	Citations
A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone Thomas Levin Andersen, Teis Esben Søndergaard, Katarzyna Skórzyńska-Dziduszko, American Journal Of Pathology MechanobiologyEngineeringBone ResorptionBiomechanicsPhysical Mechanism	2008	312
Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia Geisler Ch, JK Larsen, NE Hansen, Blood	1991	183
In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients Christian H. Geisler, Preben Philip, B. Egelund Christensen, Leukemia Research Hematological MalignancyLymphoid NeoplasiaImmunophenotypic StudyMedicineMixed-phenotype Acute Leukemia	1997	113
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma XS Xu, Xiaoyu Yan, Thomas A. Puchalski, Clinical Pharmacology & Therapeutics	2016	67
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort Johanne Marie Holst, Trine Lindhardt Plesner, Martin Bjerregård Pedersen, Haematologica	2019	26
Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia Geisler Ch, JK Larsen, NE Hansen, Blood	1991	20
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort Charlotte Bernhard Madsen, Trine Lindhardt Plesner, Hans Bentzen, Leukemia & lymphoma/Leukemia and lymphoma	2020	16
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation Marie Beck Enemark, Ida Monrad, Charlotte Bernhard Madsen, OncoTargets and Therapy	2021	16
Glycolytic biomarkers predict transformation in patients with follicular lymphoma Ida Monrad, Charlotte Madsen, Kristina Lystlund Lauridsen, PLoS ONE	2020	14
An open-label, randomised phase 3 study of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): POLLUX Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi, Haematologica-the Hematology Journal Hematological MalignancyMedicineRandomised Phase 3ImmunologyPathology	2016	13

Page 1